Form 483

Chang & Son Enterprises, Inc. Form 483, 2011-01-31

FDA issued a Form 483 to Chang & Son Enterprises, Inc. on 2011-01-31 with 10 public-safe observations.

483· Form 483 issued10 observations

Chang & Son Enterprises, Inc. · Whately, United States · Issued January 31, 2011

Overview

  • 10 public-safe observations are available for this inspection.
  • 9 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

31 Jan 2011
21 CFR 110.10(b)(1)

Suitable outer garments

Cited by Alysia M Salonia

31 Jan 2011
21 CFR 110.20(b)(4)

Drip and condensate

Cited by Alysia M Salonia

31 Jan 2011
21 CFR 110.35(a)

Buildings/sanitary

Cited by Alysia M Salonia

31 Jan 2011
21 CFR 110.35(a)

Cleaning and sanitizing operations

Cited by Alysia M Salonia

31 Jan 2011
21 CFR 110.35(d)

Failure to clean - general

Cited by Alysia M Salonia

Inspected site

C&Chang & Son Enterprises, Inc.Whately, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 110.35(a)Cited across public-safe Form 483 observations2x
21 CFR 110.10(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 110.20(b)(4)Cited across public-safe Form 483 observations1x
21 CFR 110.35(d)Cited across public-safe Form 483 observations1x
21 CFR 110.35(d)(4)Cited across public-safe Form 483 observations1x
21 CFR 110.37(b)(3)Cited across public-safe Form 483 observations1x
21 CFR 110.40(b)Cited across public-safe Form 483 observations1x
21 CFR 110.80(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 110.80(b)(7)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 10 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere